Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Accessibility StatementSkip Navigation Previously announced achievement of 50% enrollment of the NEPHRO CRRT clinical study in March 2026 and closed the associated financing tranche of $4.1 million All 12 clinical study sites now able to enroll patients to support an expected study completion in 2026 Cash and investments of $20.4 million at December 31, 2025 Fourth Quarter 2025 and Recent Highlights Fourth Q ...